Australia markets closed

Illumina, Inc. (0J8Z.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
135.18-0.89 (-0.65%)
At close: 06:20PM GMT
Full screen
Previous close136.07
Open135.57
Bid0.00 x 0
Ask0.00 x 0
Day's range134.24 - 135.86
52-week range89.21 - 238.00
Volume682
Avg. volume8,218
Market cap200.937M
Beta (5Y monthly)1.22
PE ratio (TTM)0.30
EPS (TTM)4.55
Earnings date23 Apr 2024 - 29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    15 Best Shareholder Activism Law Firms

    In this article, we discuss the 15 Best Shareholder Activism Law Firms. If you would like to discuss our detailed discussion and analysis of the shareholder activism space as of 2024, you can skip it and go directly to 5 Best Shareholder Activism Law Firms. A shareholder activist is someone who brings about changes within a […]

  • Zacks

    Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe

    In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.

  • Reuters

    Illumina, already facing pressure from Icahn, saw other activists at year end

    Gene-sequencing company Illumina, which was pushed to make changes by Carl Icahn last year, had two additional activist investors in its stock at the end of the fourth quarter, according to new regulatory filings. Keith Meister's Corvex Management disclosed buying Illumina stock during the last three months of 2023 and owning 730,084 shares on Dec. 31. The buying came after the stock price edged lower for most of the year even after investors sided with Icahn's arguments that changes were needed at the company and elected one of his director candidates to Illumina's board.